Using in vitro models, we established the ubiquitylation of NPM1 facilitated by FBXO11, providing the basis for how loss of FBXO11 could support MDS progression through disrupted splicing activity and RNA-binding protein (RBP) rewiring. This evidence concerns the gene NPM1 and myelodysplastic syndrome.